What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call
The company cited stronger reimbursement, volume growth and operational efficiencies as it lifted full-year revenue and adjusted EBITDA targets.
- On Thursday, Aveanna Healthcare Holdings Inc. reported third-quarter 2026 revenue of $695.5 million, representing 11.8% growth over the prior year period.
- Adjusted EBITDA increased 25% to $100.1 million, while net loss narrowed by $31.5 million to $14.2 million, driven by improved reimbursement rates and operational efficiencies.
- Private Duty Services achieved 38 preferred payer agreements by quarter-end, while Home Health and Hospice maintained an 80% episodic mix, exceeding the 75% target.
- Medical Solutions revenue grew 9.1% to $49.2 million while serving approximately 98,000 unique patients, completing modernization efforts and achieving long-term growth targets.
- Management raised full-year 2026 guidance to revenue exceeding $2.695 billion and adjusted EBITDA surpassing $374 million, reflecting sustained organic growth across all three operating segments.
8 Articles
8 Articles
What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call
Aveanna Healthcare (NASDAQ:AVAH) raised its full-year 2026 outlook after reporting third-quarter revenue growth across all three of its businesses and a 25% increase in adjusted earnings. The home-based care provider expects full-year revenue above $2.695 billion and adjusted earnings before intere
Gwinnett Daily Post
Aveanna: Q3 Earnings Snapshot
ATLANTA (AP) — ATLANTA (AP) — Aveanna Healthcare Holdings Inc. (AVAH) on Thursday reported third-quarter profit of $45.5 million.
Aveanna Freezes California Nurse Base Wage Hike Amid Rate Uncertainty
Uncertainty about the permanence of a California private-duty nursing reimbursement increase is holding up Aveanna Healthcare Holdings (Nasdaq: AVAH)’s plans for meaningful base-wage increases. The company plans to direct more acquisition capital toward home health and some hospice, while pursuing smaller private duty deals to enter six additional states, Aveanna’s company leaders said during its […]
What Fractyl Health (GUTS) Said on Its Q3 Earnings Call
Fractyl Health (NASDAQ:GUTS) plans to begin a U.S. marketing application for its Revita weight-maintenance procedure in late 2026, with pivotal 12-month trial results expected in the first quarter of 2027, executives said on the company’s third-quarter earnings call. The company is focusing its resources on Revita after reducing its workforce by approximately 45% and discontinuing […]
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
